Homology Medicines CEO Arthur Tzianabos' 2019 pay rises 17% to $5.1M
Homology Medicines reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Homology Medicines reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at Homology Medicines received on average a compensation package of $2.9M, a 2% increase compared to previous year.
Average pay of disclosed executives at Homology Medicines
Arthur O. Tzianabos, Chief Executive Officer, received $5.1M in total, which increased by 17% compared to 2018. 83% of Tzianabos' compensation, or $4.2M, was in option awards. Tzianabos also received $296K in non-equity incentive plan, $538K in salary, as well as $13K in other compensation.
Albert Seymour, Chief Scientific Officer, received a compensation package of $1.9M, which decreased by 12% compared to previous year. 69% of the compensation package, or $1.3M, was in option awards.
W. Bradford Smith, Chief Financial Officer, earned $1.9M in 2019.
Related executives
You may also like
Source: SEC filing on April 28, 2020.